# A Study to Identify a Biomarker Predictive for Response on Everolimus in Solid Tumors (CPCT-03)

> **NCT01566279** · NA · COMPLETED · sponsor: **UMC Utrecht** · enrollment: 73 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT01566279
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2015-11
- **Final completion:** 2016-11
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2018-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01566279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01566279, "A Study to Identify a Biomarker Predictive for Response on Everolimus in Solid Tumors (CPCT-03)". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT01566279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*